Literature DB >> 21576244

Functional relevance of a novel SlyX motif in non-conventional secretion of insulin-degrading enzyme.

Konstantin Glebov1, Sebastian Schütze, Jochen Walter.   

Abstract

Insulin-degrading enzyme (IDE) is a Zn(2+) metalloprotease with a characteristic inverted catalytic motif. IDE is ubiquitously expressed and degrades peptide substrates including insulin, endorphin, and the amyloid-β peptide. Although IDE is mainly expressed in the cytosol, it can also be found on the cell surface and in secreted form in extracellular fluids. As IDE lacks a characteristic signal sequence that targets the protein to the classical secretory pathway, release of the enzyme involves non-conventional mechanisms. However, functional domains of IDE involved in its secretion remain elusive. By bioinformatical, biochemical, and cell biological methods, we identified a novel amino acid motif ((853)EKPPHY(858)) close to the C terminus of IDE and characterized its function in the non-conventional secretion of the protein. Because of its close homology to an amino acid sequence found in bacterial proteins belonging to the SlyX family, we propose to call it the SlyX motif. Mutagenesis revealed that deletion of this motif strongly decreased the release of IDE, whereas deletion of a potential microbody-targeting signal at the extreme C terminus had little effect on secretion. The combined data indicate that the non-conventional secretion of IDE is regulated by the newly identified SlyX motif.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21576244      PMCID: PMC3123038          DOI: 10.1074/jbc.C110.217893

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Statins promote the degradation of extracellular amyloid {beta}-peptide by microglia via stimulation of exosome-associated insulin-degrading enzyme (IDE) secretion.

Authors:  Irfan Y Tamboli; Esther Barth; Leonie Christian; Martin Siepmann; Sathish Kumar; Sandesh Singh; Karen Tolksdorf; Michael T Heneka; Dieter Lütjohann; Patrick Wunderlich; Jochen Walter
Journal:  J Biol Chem       Date:  2010-09-28       Impact factor: 5.157

2.  The periplasmic Escherichia coli peptidylprolyl cis,trans-isomerase FkpA. I. Increased functional expression of antibody fragments with and without cis-prolines.

Authors:  H Bothmann; A Pluckthun
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

3.  Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques.

Authors:  H G Bernstein; S Ansorge; P Riederer; M Reiser; L Frölich; B Bogerts
Journal:  Neurosci Lett       Date:  1999-03-26       Impact factor: 3.046

4.  Insulin-degrading enzyme does not require peroxisomal localization for insulin degradation.

Authors:  V Chesneau; R K Perlman; W Li; G A Keller; M R Rosner
Journal:  Endocrinology       Date:  1997-08       Impact factor: 4.736

5.  The C-terminal domain of human insulin degrading enzyme is required for dimerization and substrate recognition.

Authors:  Pengyun Li; Wen-Liang Kuo; Mohammed Yousef; Marsha Rich Rosner; Wei-Jen Tang
Journal:  Biochem Biophys Res Commun       Date:  2006-03-22       Impact factor: 3.575

6.  Cellular localization of insulin-degrading enzyme in rat liver using monoclonal antibodies specific for this enzyme.

Authors:  H Akiyama; K Shii; K Yokono; K Yonezawa; S Sato; K Watanabe; S Baba
Journal:  Biochem Biophys Res Commun       Date:  1988-09-15       Impact factor: 3.575

7.  Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme.

Authors:  I V Kurochkin; S Goto
Journal:  FEBS Lett       Date:  1994-05-23       Impact factor: 4.124

8.  Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation.

Authors:  W Q Qiu; D M Walsh; Z Ye; K Vekrellis; J Zhang; M B Podlisny; M R Rosner; A Safavi; L B Hersh; D J Selkoe
Journal:  J Biol Chem       Date:  1998-12-04       Impact factor: 5.157

Review 9.  Classical nuclear localization signals: definition, function, and interaction with importin alpha.

Authors:  Allison Lange; Ryan E Mills; Christopher J Lange; Murray Stewart; Scott E Devine; Anita H Corbett
Journal:  J Biol Chem       Date:  2006-12-14       Impact factor: 5.157

10.  Insulin-degrading enzyme is exported via an unconventional protein secretion pathway.

Authors:  Ji Zhao; Lilin Li; Malcolm A Leissring
Journal:  Mol Neurodegener       Date:  2009-01-14       Impact factor: 14.195

View more
  15 in total

Review 1.  Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus.

Authors:  Wei-Jen Tang
Journal:  Trends Endocrinol Metab       Date:  2015-12-02       Impact factor: 12.015

2.  Vibrio vulnificus Secretes an Insulin-degrading Enzyme That Promotes Bacterial Proliferation in Vivo.

Authors:  In Hwang Kim; Ik-Jung Kim; Yancheng Wen; Na-Young Park; Jinyoung Park; Keun-Woo Lee; Ara Koh; Ji-Hyun Lee; Seung-Hoi Koo; Kun-Soo Kim
Journal:  J Biol Chem       Date:  2015-06-03       Impact factor: 5.157

3.  Domain architecture of vasohibins required for their chaperone-dependent unconventional extracellular release.

Authors:  Tetsuya Kadonosono; Wanaporn Yimchuen; Takuya Tsubaki; Tadashi Shiozawa; Yasuhiro Suzuki; Takahiro Kuchimaru; Yasufumi Sato; Shinae Kizaka-Kondoh
Journal:  Protein Sci       Date:  2017-02-11       Impact factor: 6.725

Review 4.  Unconventional protein secretion: an evolving mechanism.

Authors:  Vivek Malhotra
Journal:  EMBO J       Date:  2013-05-10       Impact factor: 11.598

5.  Phosphorylation of amyloid-β peptide at serine 8 attenuates its clearance via insulin-degrading and angiotensin-converting enzymes.

Authors:  Sathish Kumar; Sandesh Singh; Désirée Hinze; Michaele Josten; Hans-Georg Sahl; Martin Siepmann; Jochen Walter
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

6.  Insulin-degrading enzyme secretion from astrocytes is mediated by an autophagy-based unconventional secretory pathway in Alzheimer disease.

Authors:  Sung Min Son; Moon-Yong Cha; Heesun Choi; Seokjo Kang; Hyunjung Choi; Myung-Shik Lee; Sun Ah Park; Inhee Mook-Jung
Journal:  Autophagy       Date:  2016-03-10       Impact factor: 16.016

7.  Inositol phosphates and phosphoinositides activate insulin-degrading enzyme, while phosphoinositides also mediate binding to endosomes.

Authors:  Eun Suk Song; HyeIn Jang; Hou-Fu Guo; Maria A Juliano; Luiz Juliano; Andrew J Morris; Emilia Galperin; David W Rodgers; Louis B Hersh
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-21       Impact factor: 11.205

8.  Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-β hydrolysis.

Authors:  Julie Charton; Marion Gauriot; Qing Guo; Nathalie Hennuyer; Xavier Marechal; Julie Dumont; Malika Hamdane; Virginie Pottiez; Valerie Landry; Olivier Sperandio; Marion Flipo; Luc Buee; Bart Staels; Florence Leroux; Wei-Jen Tang; Benoit Deprez; Rebecca Deprez-Poulain
Journal:  Eur J Med Chem       Date:  2014-04-04       Impact factor: 6.514

9.  Insulin-degrading enzyme (IDE): a novel heat shock-like protein.

Authors:  Grazia Raffaella Tundo; Diego Sbardella; Chiara Ciaccio; Antonio Bianculli; Augusto Orlandi; Maria Giovanna Desimio; Gaetano Arcuri; Massimiliano Coletta; Stefano Marini
Journal:  J Biol Chem       Date:  2012-11-27       Impact factor: 5.157

10.  Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice.

Authors:  Rebecca Deprez-Poulain; Nathalie Hennuyer; Damien Bosc; Wenguang G Liang; Emmanuelle Enée; Xavier Marechal; Julie Charton; Jane Totobenazara; Gonzague Berte; Jouda Jahklal; Tristan Verdelet; Julie Dumont; Sandrine Dassonneville; Eloise Woitrain; Marion Gauriot; Charlotte Paquet; Isabelle Duplan; Paul Hermant; François-Xavier Cantrelle; Emmanuel Sevin; Maxime Culot; Valerie Landry; Adrien Herledan; Catherine Piveteau; Guy Lippens; Florence Leroux; Wei-Jen Tang; Peter van Endert; Bart Staels; Benoit Deprez
Journal:  Nat Commun       Date:  2015-09-23       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.